Clinical phenotypes and factor VII genotype in congenital factor VII deficiency

Summary

To investigate the relationship between clinical phenotype, clotting activity (FVIIc) and FVII genotype, a multi-center study of factor VII (FVII) congenital deficiency with centralized genotyping and specific functional assays was carried out. FVII mutations characterized in patients (n=313) were extremely heterogeneous (103 different, 22 novel). Clinical phenotypes ranged from asymptomatic condition, including 15 homozygotes and 14 double heterozygotes, to patients with a severe disease char-acterized by life-threatening and disabling symptoms (CNS, GI bleeding and hemarthrosis) strongly associated with an early age of presentation. Based on type and number of symptoms we classified 90 'severe' (median FVIIc 1.4%, IQR [Interquartile Range] 0.9–3.8), 83 'moderate' (FVIIc 3%, IQR 1–21.7), and 140 'mild' bleeders (FVIIc 14%, IQR 3–31). The significantly different FVIIc levels, and the decreasing prevalence of homozygotes or double heterozygotes among severe (98%), moderate (84%) and mild (56%) bleeders, further support our classification. The excess of females among moderate bleeders (female/male ratio =2.6) is attributable to menorrhagia. There was no evidence for modulation of clinical features by frequent functional polymorphisms. Homozygotes for the same mutation (Ala294Val; 11125del C) with similar FVIIc and FXa generation levels, showed striking differences in clinical phenotypes. Our study depicts the ample clinical picture of this rare disorder, proposes a severity classification and provides arguments for the early management of the disease in the severe cases. Genotype-phenotype relationships indicate the presence of major environmental and/or extragenic components modulating expressivity of FVII deficiency.

Keywords

Bleeding disorders - FVII deficiency - bleeding symptoms - gene mutations - polymorphisms

• References

• 1 Roberts HR, Escobar MA. Less common congenital disorders of hemostasis. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. Philadelphia: WB Saunders Company; 2002
• 2 McVey JH, Boswell E, Mumford AD. et al. Factor VII deficiency and the FVII mutation database. Hum Mutat 2001; 17: 3-17.
• 3 Triplett DA, Brandt JT, Batard MA. et al. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284-7.
• 4 Rosen ED, Zhong L, Coenelissen I. et al. Coagulation factor VII is required for embryonic development. Blood 1998; 11: 824a
• 5 Butenas S, van't Veer C, Mann KG. 'Normal' thrombin generation. Blood 1999; 94: 2169-78.
• 6 Rapaport I S, Rao LV. The tissue factor pathway: how it has become a 'prima ballerina'. Thromb Haemost 1995; 74: 7-17.
• 7 Perry DJ. Factor VII deficiency. Br J Haematol 2002; 118: 689-700.
• 8 Bernardi F, Castaman G, Pinotti M. et al. Mutation pattern in clinically asymptomatic coagulation factor VII deficiency. Hum Mutat 1996; 8: 108-15.
• 9 Millar DS, Kemball-Cook G, Mc Vey JH. et al. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000; 107: 327-42.
• 10 Peyvandi F, Jenkins PV, Mannucci PM. et al. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost 2000; 84: 250-7.
• 11 Herrmann FH, Wulff K, Auberger K. et al. Molecular biology and clinical manifestation of hereditary factor VII deficiency. Semin Thromb Hemost 2000; 26: 393-400.
• 12 Wulff K, Herrmann FH. Twenty-two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 2000; 15: 489-96.
• 13 Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C. et al Study Group of Factor Seven Deficiency. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001; 9: 105-12.
• 14 Bernardi F, Marchetti G, Pinotti M. et al. Factor VII gene polymorphisms contribute to one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16: 72-6.
• 15 Bernardi F, Patracchini P, Gemmati D. et al. Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. Hum Genet 1993; 92: 446-50.
• 16 Pinotti M, Etro D, Bindini D. et al. Residual factor VII activity and different hemorrhagic phenotypes in CRM(+) factor VII deficiencies (Gly331Ser and Gly283Ser). Blood 2002; 99: 1495-7.
• 17 Campbell MJ, Gardner MJ. Calculating confidence intervals for some non-parametric analyses. Br Med J 1988; 296: 1454-6.
• 18 Siegel S, Castellan NJ. Non Parametric Statistics for the Behavioral Sciences. New York: McGraw-Hill; 1988
• 19 Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000
• 20 Green F, Kelleher C, Wilkes H. et al. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-6.
• 21 Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iraq patients with type 3 von Willebrand disease. Br J Haematol 2000; 111: 1236-9.
• 22 Kadir RA, Economides DL, Sabin CA. et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
• 23 Giansily-Blaizot M, Verdier R, Biron-Adreani C. et al. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?. Haematologica 2004; 89: 704-9.